Oncopure trademark, custom biological products, oncology applications

← USPTO Trademark Applications

ONCOPURE

Intent to Use TM99112549 Kind: intenttouse Mar 31, 2026

Abstract

Custom manufacture of cell line-delivered products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for medical and commercial applications; Custom manufacture of reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids; Biological preparations for laboratory, biopharmaceutical processing, and research purposes, for use as reference standards in science; Chemicals for use in the research of anti-cancer drugs; Biological preparations for quality control of laboratory research; Cell line-derived nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for use as reference standards for research purpose; Samples made of nucleic acids for use in biochemical or biological laboratory analysis for research purposes; Samples made of formalin and nucleic acids for use in a biochemical or biological laboratory analysis for research purposes; Samples made of formalin and cells for use in a biochemical or biological laboratory analysis for research purposes; Cell line-derived products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for scientific and research purposes, namely, for clinical investigations and for use in product testing; Reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for research purposes, namely, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; cell line-derived reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used in clinical medical samples; reference standard substances in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for clinical tests for medical purposes; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for detecting chromosomal abnormalities; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for analysing biological samples

Filing Date

2025-03-31

View original document →